NEW YORK, Feb. 13, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of AstraZeneca PLC (NASDAQ: AZN). Shareholders who purchased shares of AZN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment….
Category: Uncategorized
NEW YORK, Feb. 13, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Capri Holdings Limited (NYSE: CPRI). Shareholders who purchased shares of CPRI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff…
NEW YORK, Feb. 13, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Transocean Ltd. (NYSE: RIG). Shareholders who purchased shares of RIG during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment….
NEW YORK, Feb. 13, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Caribou Biosciences, Inc. (NASDAQ: CRBU). Shareholders who purchased shares of CRBU during the class period listed are encouraged to contact the firm regarding possible lead plaintiff…
NEW YORK, Feb. 13, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Revance Therapeutics, Inc. (NASDAQ: RVNC). Shareholders who purchased shares of RVNC during the class period listed are encouraged to contact the firm regarding possible lead…
NEW YORK, Feb. 13, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of ESSA Pharma Inc. (NASDAQ: EPIX). Shareholders who purchased shares of EPIX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff…
NEW YORK, Feb. 13, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Integral Ad Science Holding Corp. (NASDAQ: IAS). Shareholders who purchased shares of IAS during the class period listed are encouraged to contact the firm regarding possible lead…
NEW YORK, Feb. 13, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Novo Nordisk A/S (NYSE: NVO). Shareholders who purchased shares of NVO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment….
NEW YORK, Feb. 13, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of GSK plc (NYSE: GSK). Shareholders who purchased shares of GSK during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment….
NEW YORK, Feb. 13, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Neumora Therapeutics, Inc. (NASDAQ: NMRA). Shareholders who purchased shares of NMRA during the class period listed are encouraged to contact the firm regarding possible lead…